TRPV1 and cancer: Our data shed light on the molecular mechanisms regulating TRPV1 activity during pain resolution, suggesting that targeting TRPV1 palmitoylation could mitigate clinically intractable chronic pain, such as neuropathic pain, cancer-related pain, and various forms of chronic inflammatory pain.